VSTM (VSTM) Earnings Call Analysis
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
VeriSTEM Oncology (VSTM) Q1 2026: COPAQ Prescriber Base Expands to 400, Launching Next-Phase Growth
May 08, 2026
-
Veristem Oncology (VSTM) Q4 2025: COPAQ Launch Drives $17.5M Revenue, Pipeline Progress Sets Up 2026 Catalysts
March 05, 2026
-
Verisim Oncology (VSTM) Q3 2025: 133 Prescribers Drive First Full Quarter Launch Momentum
November 04, 2025